or Try an Advanced Search...

    Glucose Meter Stocks List

    Symbol Grade Name % Change
    TNDM A Tandem Diabetes Care, Inc. -0.90
    SNY C Sanofi -0.47
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Medical Devices
    Related Stock Lists: Glucose Insulin Animal Health Cac 40 Cancer Caregiver Chronic Kidney Disease Clopidogrel Colorectal Cancer Consumer Health Care Consumer Health Care Products Deep Vein Thrombosis Diabetes Diabetes Care Diabetes Management Diabetes Mellitus Diabetes Mellitus Type 1 Dialysis Endocrine System Endocrinology

    Related ETFs - A few ETFs which own one or more of the above listed Glucose Meter stocks.

    Symbol Grade Name Weight
    EDOC D Global X Telemedicine & Digital Health ETF 4.72
    PPH C Market Vectors Pharmaceutical ETF 4.64
    VIRS C Pacer BioThreat Strategy ETF 4.06
    PID C PowerShares Intl Dividend Achievers 2.97
    PVAL A Putnam Focused Large Cap Value ETF 2.27
    View all Glucose Meter ETFs...
    Compare ETFs
    Compare EDOC to VIRS Compare PPH to PVAL Compare VIRS to PID

        Glucose Meter Stocks Recent News

        Date Stock Title
        Apr 26 SNY Bristol, Sanofi, Takeda gain positive CHMP recommendations
        Apr 26 SNY Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
        Apr 25 SNY AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
        Apr 25 SNY Sanofi 2024 Q1 - Results - Earnings Call Presentation
        Apr 25 SNY 20 Fastest Growing Health Tech Companies in the World
        Apr 25 SNY Sanofi (SNY) Q1 2024 Earnings Call Transcript
        Apr 25 SNY Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up
        Apr 25 SNY AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
        Apr 25 TNDM Earnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q1 Earnings Expected to Decline
        Apr 25 SNY US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst
        Apr 25 SNY Sanofi Sales, Profit Beat Expectations
        Apr 25 SNY UPDATE 2-Sanofi profit slips on generic competition and currency effects
        Apr 25 SNY Sanofi Non-GAAP EPS of €1.78, revenue of €10.46B; reaffirms FY24 business EPS guidance
        Apr 25 SNY Sanofi profit slips on generic competition and currency effects
        Apr 25 SNY Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
        Apr 24 SNY What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
        Apr 23 SNY Sanofi reportedly lining up banks for consumer products spinoff
        Apr 23 SNY Sanofi Asks Banks to Pitch for $20 Billion OTC Spinoff
        Apr 23 SNY Sanofi (SNY) Rilzabrutinib Shows Benefit in Blood Disorder Study
        Apr 23 SNY Sanofi succeeds in late-stage trial for blood disorder candidate
        Related Industries: Drug Manufacturers - Major Medical Devices
        Related Stock Lists: Glucose Insulin Animal Health Cac 40 Cancer Caregiver Chronic Kidney Disease Clopidogrel Colorectal Cancer Consumer Health Care Consumer Health Care Products Deep Vein Thrombosis Diabetes Diabetes Care Diabetes Management Diabetes Mellitus Diabetes Mellitus Type 1 Dialysis Endocrine System Endocrinology
        Glucose Meter

        A glucose meter is a medical device for measuring the amount of glucose in the blood. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained by pricking the skin with a lancet, is placed on a disposable test strip that the meter reads and uses to calculate the blood glucose level. The meter then displays the level in mg/dl or mmol/l.

        Browse All Tags